本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tempest Therapeutics Inc.

0.7554
-0.0289-3.68%
盤前1.150.3940+52.16%04:20 EDT
成交量:2,644.34萬
成交額:3,007.66萬
市值:1,249.41萬
市盈率:-0.17
高:0.8094
開:0.7990
低:0.7432
收:0.7843
52周最高:12.23
52周最低:0.7432
股本:1,653.98萬
流通股本:1,146.07萬
量比:77.43
換手率:230.73%
股息:- -
股息率:- -
每股收益(TTM):-4.5617
每股收益(LYR):-19.4955
淨資產收益率:-931.14%
總資產收益率:-79.37%
市淨率:-11.46
市盈率(LYR):-0.04

資料載入中...

2024/08/08

重要事件披露

Form 8-K - Current report
2024/06/20

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/13

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/03/19

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/19

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/19

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/18

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/18

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/18

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/18

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/18

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/17

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/09

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]